Sennosides Market

Market Overview

Sennosides s i.e. the Senna glycoside or Senna is a drug used for the treatment of constipation and helpful in emptying the large intestine in surgery. The drug is administered by the oral or rectum route.

It shows immediate therapeutic action when administered through the rectum route and it takes twelve hours when administered by the oral route. Sennosides invigorates peristalsis and rises faecal water substance to expand motility of defecation through the large intestine.

Sennosides is the FDA-approved OTC laxative which is used to treat constipation and also helpful in cleaning the bowel before a colonoscopy. Additionally, it is used in irritable bowel syndrome, haemorrhoids, rectal surgery, weight loss & anal fissures.

The COVID-19 situation has a positive impact at the sennosides market, i.e. the lockdown & restricted movements of the people has made changes in their eating habits including resting patterns with changing lifestyle.

All these factors led to disturbance of the normal routine of the person which is initiating with the problems of gastrointestinal disorders that is propelling the growth of th3e sennosides market.

Sennosides Market: Drivers and Restraints

Increasing prevalence of gastrointestinal disorders, changes in lifestyle, dietary habits, increasing surgeries and high population rate are the driving factors responsible for the growth of the sennosides market. Moreover, the hectic schedule & changes in eating patterns i.e. irregular timings of food, contaminated foods, and junk food led to gastrointestinal disorders which are fueling the growth of the sennosides market.

Meanwhile, rising awareness of therapeutic benefits and lack of serious complications are boosting the growth of the market. On the contrary adverse effects like stomach pain, headache & nausea is restraining the growth of the market.

Aside from this, the drug is contraindicated for the utilization in patients suffering from diarrhoea or in pregnancy.

Sennosides Market: Overview

Sennoside A is mostly utilised as compared with sennosides B as it acts in the laxatives, which has demonstrated viable results in repressing the ribonuclease H (RNase H) action of human immunodeficiency infection (HIV) invert transcriptase 1.

Thus due to increased utilization of sennosides A is boosting the growth of the sennosides market. Moreover, it is mostly used in the pharmaceutical industry due to the increasing prevalence of gastrointestinal disorders and surgeries.

While the sennosides are widely used in the preparation of cathartics & laxatives. Meanwhile, it is found in the form of tablets as the oral route of drug administration is the most conveyance form of drug administration. Thus increasing prevalence of gastrointestinal disorders is providing a lucrative growth opportunity during the forecasted period.

Sennosides Market: Regional Wise Outlook

Geographically, the Sennosides market is divided into seven regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, China, Japan & the Middle East and Africa.  Asia-Pacific is expected to dominate the global Sennosides market followed by North- America & Europe.

Asia-Pacific is dominating the global Sennosides market due to the increasing prevalence of gastrointestinal disorder. As the population of developing countries (India & china) are higher, the incidences of GIT disorders are increasing amongst the population owing to the hectic schedule, lifestyle changes, and changes in dietary habits (junk food).

Moreover, most of the people are consuming it for increasing the metabolism of the food along with the health benefits. Moreover, the lack of serious adverse reactions is the major factor in boosting the growth of the sennosides market. Thus, all these factors are propelling the sennosides regional market.

Rapid development & Advancements along with the changing snacking tendency is going to offer a lucrative opportunity for the growth of sennosides market at North America during the forecasted period.

Sennosides Market: Key Market Participants

The key participants operating in the global Sennosides market identified across the value chain include

• Pai pharmaceutical Associates, Inc.
• Madaus 
• NOW Health Group Inc. (Now Foods)
• Changsha Vigorous-Tech 
• Vital Laboratories
• Health and Herbs 
• Alchem International
• Shaanxi Hongda Phytochemistry
• Nutra Green Biotechnology Co. Ltd 
• Elixir Natural Labs
• Shaanxi Jintai Biological Engineering 
• Alps Pharmaceutical 
• Shashi Phytochemical Industries 
• Shaanxi huadong Biological Technology Co. Ltd. 
• Kattwiga
• SAB Herbals & Nutraceuticals 
• Santen 
• Apex International 
• Xi'an Wonderful Herb Biotechnology 
• Wuhan Vanz Pharm
• Xi'an Lyphar Biotech 
• Kothari Phytochemicals 
• SHASHI PHYTOCHEMICAL INDUSTRIES.

The players working in the worldwide Sennosides market are concentrating on the drug discovery i.e. by combining the drug with various other extracts for the development of new therapeutic medication which would be helpful in prevention & cure of various disorders.

The Report Covers Exhaust Analysis On

• Sennosides market Segments
• Sennosides Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional Analysis Includes

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (India, China ASEAN, Australia & New Zealand)
• Japan
• The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Report Highlights

• Detailed overview of the Fast-moving consumer goods market
• Changing Sennosides market dynamics in the industry
• Below the Sennosides market -depth market segmentation
• Historical, current, and projected market size in terms of volume and value
• Below the Sennosides market recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint